Table II.
The results of Newcastle–Ottawa Scale (NOS) [18] performed for 19 cohort studies
| Author(s) | Cohort studies | Selection |
Comparability |
Outcome/exposure |
Total of 9 scores |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | (∗∗) | a | b | c | |||
| Alanio et al. [21] | Prospective cohort | ∗ | ∗ | ∗ | ∗ | N/A | ∗ | ∗ | ∗ | 7 |
| Bartoletti et al. [22] | Prospective cohort | ∗ | ∗ | ∗ | ∗ | ∗∗ | ∗ | ∗ | ∗ | 9 |
| Chauvet et al. [26] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | ∗∗ | ∗ | ∗ | ∗ | 9 |
| Delliere et al. [25] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | ∗∗ | ∗ | ∗ | ∗ | 9 |
| Dupont et al. [43] | Prospective cohort | ∗ | ∗ | ∗ | ∗ | N/A | ∗ | ∗ | ∗ | 7 |
| Gangneux et al. [15] | Prospective cohort | ∗ | ∗ | ∗ | ∗ | ∗∗ | ∗ | ∗ | ∗ | 9 |
| Helleberg et al. [60] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | N/A | ∗ | ∗ | ∗ | 7 |
| Koehler et al. [28] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | N/A | ∗ | ∗ | ∗ | 7 |
| Lahmer et al. [29] | Prospective cohort | ∗ | ∗ | ∗ | ∗ | ∗∗ | ∗ | ∗ | ∗ | 9 |
| Lamoth et al. [42] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | N/A | ∗ | ∗ | ∗ | 7 |
| Machado et al. [24] | Prospective cohort | ∗ | ∗ | ∗ | ∗ | ∗∗ | ∗ | ∗ | ∗ | 9 |
| Meijer et al. [61] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | ∗∗ | ∗ | ∗ | ∗ | 9 |
| Nasir et al. [19] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | N/A | ∗ | ∗ | ∗ | 7 |
| Roman-Montes et al. [27] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | 8 |
| Rutsaert et al. [20] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | N/A | ∗ | ∗ | ∗ | 7 |
| Van Arkel et al. [62] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | 8 |
| Van Biesen et al. [23] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | ∗∗ | ∗ | ∗ | ∗ | 9 |
| Velez Pintado et al. [63] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | ∗ | 8 |
| Versyck et al. [64] | Retrospective cohort | ∗ | ∗ | ∗ | ∗ | ∗∗ | ∗ | ∗ | ∗ | 9 |
1: Representatives of the exposed cohorts. 2: Selection of the non-exposed cohorts. 3: Ascertainment of exposure. 4: The outcome of interest was not present at the start of the study. a: Assessment of the outcome. b: Enough follow-up for the outcome. c: Adequacy of follow-up. N/A, non-available.